FDA approves weight-loss drug Zepbound for obstructive sleep apnea - KSBW

FDA approves weight-loss drug Zepbound for moderate to severe obstructive sleep apnea in obese individuals, to be used with diet and exercise. Clinical trials showed significant improvements in sleep apnea symptoms and weight loss, with potential for insurance coverage under Medicare.